Issued Patents 2022
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11473061 | Systems and methods for growth of intestinal cells in microfluidic devices | Robert Barrett, Clive Svendsen, Michael Workman, Dhruv Sareen, Uthra Rajamani | 2022-10-18 |
| 11440954 | Optimized anti-TL1A antibodies | Jeffry D. Watkins, Cindy T. Dickerson, J. Monty Watkins, Patricia McNeeley, Janine Bilsborough +1 more | 2022-09-13 |
| 11434296 | Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function | David Q. Shih, Dalin Li, Janine Bilsborough | 2022-09-06 |
| 11312768 | Signature of TL1A (TNFSF15) signaling pathway | Kathrin S. Michelsen | 2022-04-26 |
| 11292848 | Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof | Jeffry D. Watkins, Cindy T. Dickerson, Rafael Rojas, Matthew Reissman, Patricia McNeeley +2 more | 2022-04-05 |
| 11268149 | Diagnosis and treatment of inflammatory bowel disease | Marla C. Dubinsky, Carol J. Landers, Ling Mei, Jerome I. Rotter, Kent D. Taylor | 2022-03-08 |
| 11236393 | Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease | Jerome I. Rotter, Marla C. Dubinsky, Kent D. Taylor | 2022-02-01 |